ARAY 财务： Accuray Inc AI 分析

主页

股票

ARAY

ARAY 财务

Accuray Inc

$0.38

-10.31%

$-0.04

收盘价：Mar 20, 16:00:00 GMT-4

$0.38

盘前：Mar 23, 04:12:29 GMT-4

概述预测收益股息财务数据

关键数据

前收盘价

$0.4305

开盘价

$0.44

当日区间

$0.3821 - $0.444

52周范围

$0.33 - $2.1

交易量

1.5M

平均成交量

1.1M

股息收益率

每股收益（TTM）

-0.30

市值

$45.8M

什么是 ARAY？

Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. The company is headquartered in Madison, Wisconsin and currently employs 990 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.

功能特性

资源

市场

收入

资产负债表

现金流量

年度

季度性

ARAY 收入

以百万美元为单位的财务数据。财年为2月至次年1月。

Breakdown	TTM	06/30/2025	06/30/2024	06/30/2023	06/30/2022	06/30/2021
营收	436	458	446	447	429	396
营收同比增长 (YoY)	-4%	3%	0%	4%	8%	4%
营收成本	315	311	303	293	270	236
毛利润	121	146	143	154	160	159
销售、一般及管理费用	86	91	91	94	94	84
研发	44	47	48	57	57	52
营业费用	130	139	140	151	151	137
其他非经营性收入 (费用)	0	0	0	0	0	1
税前利润	-33	1	-11	-6	-2	-4
所得税费用	2	2	3	2	3	1
净利润	-35	-1	-15	-9	-5	-6
净利润增长	775%	-93%	67%	80%	-17%	-300%
稀释后流通股数	120.97	102.76	98.27	94.9	92.1	92
股份同比变动 (YoY)	17%	5%	4%	3%	0%	2%
每股收益 (摊薄)	-0.29	-0.01	-0.15	-0.1	-0.06	-0.07
每股收益增长率	564%	-90%	57.99%	67%	-14%	-275%
自由现金流	-2	-1	-15	2	-7	36
每股自由现金流	--	--	--	--	--	--
毛利率	27.75%	31.87%	32.06%	34.45%	37.29%	40.15%
营业利润率	-1.83%	1.52%	0.67%	0.44%	1.86%	5.55%
净利率	-8.02%	-0.21%	-3.36%	-2.01%	-1.16%	-1.51%
自由现金流利润率	-0.45%	-0.21%	-3.36%	0.44%	-1.63%	9.09%
EBITDA	-1	13	8	6	13	28
EBITDA 利润率	-0.22%	2.83%	1.79%	1.34%	3.03%	7.07%
EBITDA 中的折旧与摊销	7	6	5	4	5	6
EBIT	-8	7	3	2	8	22
EBIT 利润率	-1.83%	1.52%	0.67%	0.44%	1.86%	5.55%
有效税率	-6.06%	200%	-27.27%	-33.33%	-150%	-25%

Follow-Up Questions

Accuray Inc 的关键财务报表是什么？



根据最新的财务报表（Form-10K），Accuray Inc 的总资产为 $470，净损失为 $-1

ARAY 的关键财务比率是什么？



Accuray Inc 的流动比率是 1.2，净利 margin 为 -0.21，每股销售为 $4.45。

Accuray Inc 的收入按细分市场或地理位置如何划分？



Accuray Inc 最大收入来源是 Oncology Systems Products，在最近的收益报告中收入为 234,164,000。就地区而言， Europe, Middle East, India and Africa 是 Accuray Inc 的主要市场，收入为 168,611,000。

Accuray Inc 是否盈利？



不，根据最新的财务报表，Accuray Inc 的净损失为 $-1

Accuray Inc 有负债吗？



是的，Accuray Inc 的负债为 389

Accuray Inc 的流通股有多少？



Accuray Inc 的总流通股为 112.64

Accuray Inc（ARAY）价格

ARAY 股价走势图